Search

Janet A Takeuchi

from Anaheim, CA
Age ~57

Janet Takeuchi Phones & Addresses

  • 8195 Bailey Way, Anaheim, CA 92808 (714) 281-8867
  • 8195 Bailey Way #E, Anaheim, CA 92808 (714) 281-8867
  • 8251 Blackwillow Cir, Anaheim, CA 92808
  • 8251 E Blackwillow Cir #104, Anaheim, CA 92808
  • Anaheim Hills, CA
  • Monterey Park, CA
  • 950 W Linden St #52, Riverside, CA 92507 (951) 264-0613
  • Bloomington, IN
  • 8195 E Bailey Way, Anaheim, CA 92808

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

Publications

Us Patents

Compounds Having Selective Cytochrome P450Rai-1 Or Selective Cytochrome P450Rai-2 Inhibitory Activity And Methods Of Obtaining The Same

View page
US Patent:
7226951, Jun 5, 2007
Filed:
Dec 16, 2004
Appl. No.:
11/014460
Inventors:
Jayasree Vasudevan - Anaheim CA, US
Liming Wang - Irvine CA, US
Xiaoxia Liu - Tustin CA, US
Kwok Yin Tsang - Irvine CA, US
Ling Li - Irvine CA, US
Janet A. Takeuchi - Anaheim CA, US
Thong Vu - Garden Grove CA, US
Richard Beard - Newport Beach CA, US
Smita Bhat - Irvine CA, US
Vidyasagar Vuligonda - Irvine CA, US
Roshantha A. Chandraratna - Laguna Hills CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/135
C07C 62/00
C07C 69/52
C07C 211/16
US Classification:
514654, 562500, 564384
Abstract:
Compounds of formulas 1 through 17 provided in the specification specifically or selectively inhibit either the cytochrome P450RAI-1 enzyme or the cytochrome P450RAI-2 enzyme.

Methods For Treating Retinoid Responsive Disorders Using Selective Inhibitors Of Cyp26A And Cyp26B

View page
US Patent:
7468391, Dec 23, 2008
Filed:
Dec 13, 2004
Appl. No.:
11/010953
Inventors:
Jayasree Vasudevan - Anaheim CA, US
Rong Yang - Viejo CA, US
Liming Wang - Irvine CA, US
Xiaoxia Liu - Nashua NH, US
Ling Li - Irvine CA, US
Janet Takeuchi - Anaheim CA, US
Thong Vu - Garden Grove CA, US
Richard Beard - Newport Beach CA, US
Smita Bhat - Irvine CA, US
Roshantha A. Chandraratna - Laguna Hills CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A01N 31/00
A61K 9/00
A61K 31/415
A61K 9/20
A61K 9/48
US Classification:
514567, 424400, 424404
Abstract:
The invention provides methods for treating an individual having a retinoid responsive disorder. In one embodiment, a method involves administering to the individual an effective amount of a selective CYP26B inhibitor, the selective CYP26B inhibitor having at least 10-fold selectivity for CYP26B relative to CYP26A. In another embodiment, a method involves administering to the individual an effective amount of a selective CYP26A inhibitor, the selective CYP26A inhibitor having a chemical formula set forth in the specification. The invention further provides screening methods for identifying a selective CYP26A inhibitor or selective CYP26B inhibitor.

Compounds Having Selective Cytochrome P450Rai-1 Or Selective Cytochrome P450Rai-2 Inhibitory Activity And Methods Of Obtaining The Same

View page
US Patent:
7638648, Dec 29, 2009
Filed:
Mar 23, 2007
Appl. No.:
11/728313
Inventors:
Jayasree Vasudevan - Anaheim CA, US
Liming Wang - Irvine CA, US
Xiaoxia Liu - Tustin CA, US
Kwok Yin Tsang - Irvine CA, US
Ling Li - Irvine CA, US
Janet A. Takeuchi - Anaheim CA, US
Thong Vu - Garden Grove CA, US
Richard Beard - Newport Beach CA, US
Smita Bhat - Irvine CA, US
Vidyasagar Vuligonda - Irvine CA, US
Roshantha A. Chandraratna - Laguna Hills CA, US
Assignee:
Allergan Inc. - Irvine CA
International Classification:
C07D 265/06
C07D 263/02
C07D 277/02
C07D 213/02
C07D 333/04
C07D 307/34
C07C 229/34
US Classification:
562433, 562442, 562452, 562488, 562492, 549332, 549398, 549405, 549408, 549429, 548146, 548206, 548215, 548240, 546329
Abstract:
Compounds of formulas 1 through 17 provided in the specification specifically or selectively inhibit either the cytochrome P450RAI-1 enzyme or the cytochrome P450RAI-2 enzyme.

Α2B And Α2C Agonists

View page
US Patent:
8080570, Dec 20, 2011
Filed:
May 1, 2009
Appl. No.:
12/433953
Inventors:
Janet A. Takeuchi - Anaheim CA, US
Ken Chow - Newport Coast CA, US
Ling Li - Irvine CA, US
Liming Wang - Irvine CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A01N 43/76
A61K 31/42
C07D 413/00
C07D 263/00
US Classification:
514377, 548233
Abstract:
Described herein are compounds that can be useful as bioactive agents. More specifically, the compounds described herein can be useful as both αand αadrenergic agonists. Methods of synthesis and administration of the compounds are also disclosed.

N-(1-Phenyl-2-Arylethyl)-4,5-Dihydro-2H-Pyrrol-5-Amine Compounds As Subtype Selective Modulators Of Alpha2B Or Alpha2B And Alpha2C Adrenoceptors

View page
US Patent:
8183414, May 22, 2012
Filed:
Dec 7, 2009
Appl. No.:
12/632494
Inventors:
Ken Chow - Newport Coast CA, US
Janet A. Takeuchi - Anaheim CA, US
Ling Li - Irvine CA, US
Todd M. Heidelbaugh - Fountain Valley CA, US
Phong X. Nguyen - Placentia CA, US
Evelyn G. Corpuz - Irvine CA, US
Wenkui K Fang - Irvine CA, US
Santosh C. Sinha - Ladera Ranch CA, US
Michael E. Garst - Newport Beach CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
C07C 257/00
A61K 31/155
US Classification:
564244, 514637
Abstract:
The present invention provides compounds which are N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds and are subtype selective modulators of alpha 2B or alpha 2B and alpha 2C adrenoreceptors and are selected from the group of compounds represented by the formula.

Biphenyl Oxadiazole Derivatives As Sphingosine-1-Phosphate Receptors Modulators

View page
US Patent:
8273776, Sep 25, 2012
Filed:
Apr 13, 2011
Appl. No.:
13/086071
Inventors:
Janet A. Takeuchi - Anaheim CA, US
Ken Chow - Newport Coast CA, US
Ling Li - Irvine CA, US
Assignee:
Allergan, Inc - Irvine CA
International Classification:
A61K 31/4245
C07D 271/06
US Classification:
514364, 548131
Abstract:
The present invention relates to novel biphenyl oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.

3-(4-((1-Imidazol-1-Yl)Methyl)Phenyl)-5-Aryl-1,2,4-Oxadiazole Derivatives As Sphingosine-1 Phosphate Receptors Modulators

View page
US Patent:
8318783, Nov 27, 2012
Filed:
Apr 13, 2011
Appl. No.:
13/085868
Inventors:
Janet A. Takeuchi - Anaheim CA, US
Ken Chow - Newport Coast CA, US
Ling Li - Irvine CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/4245
C07D 413/10
US Classification:
514364, 548131
Abstract:
Substituted 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-phenyl-1,2,4-oxadiazole derivatives which are useful as sphingosine-1-phosphate modulators and useful for treating a wide variety of disorders associated with modulation of sphingosine-1-phosphate receptors.

Selective Subtype Alpha 2 Adrenergic Agents And Methods For Use Thereof

View page
US Patent:
8362022, Jan 29, 2013
Filed:
Jan 14, 2009
Appl. No.:
12/811773
Inventors:
Todd M. Heidelbaugh - Fountain Valley CA, US
Ken Chow - Newport Coast CA, US
Santosh C. Sinha - Ladera Ranch CA, US
Phong X. Nguyen - Placentia CA, US
Wenkui K. Fang - Irvine CA, US
Ling Li - Irvine CA, US
Janet A. Takeuchi - Anaheim CA, US
Smita S. Bhat - Irvine CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/497
A61K 31/4439
US Classification:
51425505, 514341, 544336, 5462747
Abstract:
The invention provides well-defined heterocyclic compounds that are useful as subtype selective alpha 2 adrenergic agonists. As such, the compounds described herein, having the structure:.
Janet A Takeuchi from Anaheim, CA, age ~57 Get Report